Citations

Mayo Clinic

Clear

2 citation(s) found for "Machnitz, Andrea Judit".

Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Barth, Matthew J. , Audino, Anthony , Blazin, Lindsay , Chung, Jong , Davies, Kimberly, Ding, Hilda, Ford, James B. , Galardy, Paul J. , Hanna, Rabi , Hayashi, Robert J. , Lee‐Miller, Cathy , Machnitz, Andrea Judit, Maloney, Kelly W. , Marks, Lianna J. , Martin, Paul L. , Pacheco, Martha, Reilly, Anne F. , Roshal, Mikhail , Song, Sophie X. , Weinstein, Joanna , Zarnegar‐Lumley, Sara , McMillian, Nicole R., Schonfeld, Ryan, Sundar, Hema, Blazin, Lindsay J , Xavier, Ana C , Armenian, Saro H. , Bloom, David E. , McCall, David C.

Journal of the National Comprehensive Cancer Network | November 9, 2022 | Volume: 20 | Issue: 11 | Pages: 1267-1275

10.6004/jnccn.2022.0057 | PMID 36351334 Get It

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Aggressive Mature B-Cell Lymphomas include recommendations for the diagnosis and management of pediatric patients with primary mediastinal large B-cell lymphoma (PMBL) and sporadic variants of Burkitt lymphoma and diffuse large B-cell lymphoma. PMBL is now considered as a distinct entity arising from mature thymic B-cells accounting for 2% of mature B-cell lymphomas in children and adolescents. This discussion section includes the recommendations outlined in the NCCN Guidelines for the diagnosis and management of pediatric patients with PMBL.
Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Davies, Kimberly, Barth, Matthew J. , Audino, Anthony , Barnette, Phillip, Cuglievan, Branko , Ding, Hilda, Ford, James B. , Galardy, Paul J. , Hanna, Rabi , Hayashi, Robert J. , Kovach, Alexandra E. , Machnitz, Andrea Judit, Maloney, Kelly W. , Marks, Lianna J. , Page, Kristin , Reilly, Anne F. , Weinstein, Joanna , McMillian, Nicole R., Freedman-Cass, Deborah A., Kovach, Alexandra E , Armenian, Saro H. , Gardner, Rebecca Alice , Xavier, Ana C

Journal of the National Comprehensive Cancer Network | August 5, 2020 | Volume: 18 | Issue: 8 | Pages: 1105-1123

10.6004/jnccn.2020.0036 | PMID 32755986 Get It

Pediatric aggressive mature B-cell lymphomas are the most common types of non-Hodgkin lymphoma in children, and they include Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL). These diseases are highly aggressive but curable, the treatment is complex, and patients may have many complicated supportive care issues. The NCCN Guidelines for Pediatric Aggressive Mature B-Cell Lymphomas provide guidance regarding pathology and diagnosis, staging, initial treatment, disease reassessment, surveillance, therapy for relapsed/refractory disease, and supportive care for clinicians who treat sporadic pediatric BL and DLBCL.